Absci and AMD Announce Collaboration and Strategic
VANCOUVER, Washington, January 8, 2025 (GLOBE NEWSWIRE) — Absci Company (NASDAQ: ABSI), a data-driven generative AI drug creation company, today announced a strategic collaboration with AMD to deploy AMD Instinct™ accelerators and ROCm™ software to power critical AI drug discovery workloads, including advanced Absci capabilities new Antibody design models. AMD will also invest $20 million…